Mergers & Acquisitions

Walmart acquired the technology platform, patents and intellectual property of CareZone, which helps people manage their health information and medications.

Jean-Michel Boers will succeed Wolfgang Baiker, as the company's U.S. country managing director, president and CEO, effective Aug. 1.

Dr. Reddy's will manufacture remdesivir, Gilead's investigational antiviral therapy used to treat COVID-19.

The product, a "follow-on" biologic of Sanofi's Lantus, has been approved in both vial and prefilled pen presentations.

Stop & Shop and King Kullen decided not to proceed with the acquisition due to unforeseen changes in the marketplace, the companies said.

Dr. Reddy's is acquiring Wockhardt's branded generics, which include respiratory, neurology, VMS, dermatology, gastroenterology, pain and vaccines.

MaxorPlus clients can choose Amber Pharmacy’s service model for members with organ transplant medication needs.

An AstraZeneca merger with Gilead — which Bloomberg reported is being preliminarily discussed by the companies — would be a record-breaking deal in health care.